In general, conjugation dramatically improves solubility, which then promotes rapid excretion
Multiple well-designed clinical trials have demonstrated SFNs biological activity and therapeutic potential, while also revealing important considerations for its clinical implementation ( Figure 3 )
doi: 10.1093/brain/awx137 7 AytonS.LeiP.BushA
[ Links ] 20
Environmental Protectional Agency
XPP treatment altered expression of genes involved in B cell differentiation and plasma cell IgE production, including cyclin d1 (CCND1), dual specificity phosphatase 4 (DUSP4), syndecan -1 (SDC1), erythroblastosis virus proto-oncogene 1 (ETS1), protein tyrosine phosphatase, receptor type, C (PTPRC), and IL-6R (Fig